Portal Navigation Links (Level 1):
Residents |
Government |
Business |
Culture
Portal Navigation Links (Level 2):
News | County
Executive | County Council | Departments
| Services (A to Z)
| Online Services
County Cable 6 | Transportation
| Education |
Careers | Volunteers
| Contact Us
Fire & Rescue Navigation Links:
| |
|
|||||
|
|
|
|
|
|
|
Leukotrine Modifiers
Leukotrine Modifiers are medications that interrupt the body's normal response to allergens, thus preventing asthma attacks in some patients. Asthmatics with primarily chemical triggers may have limited benefit from this family of drugs. Click on the medication name below to view more details.
montelukast
sodium
Singular
zafirlukast
Accolate
zileuton
Zyflo
Singular®
(montelukast sodium)
Quiet Drug:
Oral leukotriene modifier
Singular (montelukast sodium) is a leukotriene modifier, a drug that interferes with the normal allergic response thus preventing bronchospasm, airway edema and inflammation.
Singular® is NOT to be administered by EMTBs per Maryland Medical Protocols
Drug
Action:
Leukotriene
modifier (antiasthmatic)
Dose:
5-10 mg daily in the evening
Supplied
as:
Singular 4mg chewable tablets Singular 5 mg chewable tablets Singular 10 mg tablets
Accolate®
(zafirlukast)
Quiet Drug:
Oral leukotriene modifier
Accolate (zafirlukast) is a leukotriene modifier, a drug that interferes with the normal allergic response thus preventing bronchospasm, airway edema and inflammation. It inhibits bronchoconstriction in asthmatics caused by cold air and by sulfur dioxide as well as reducing the allergic response to some allergens.
Accolate® is NOT to be administered by EMTBs per Maryland Medical Protocols
Drug
Action:
Leukotriene
modifier (antiasthmatic)
Dose:
20 mg b.i.d.
Supplied
as:
20 mg tablets
Zyflo™ filmtab®
(zileuton)
Quiet Drug:
Oral leukotriene modifier
Zyflo (zileuton) is a leukotriene modifier, a drug that interferes with the normal allergic response thus preventing bronchospasm, airway edema and inflammation. It inhibits bronchoconstriction in asthmatics caused by cold air as well as reducing the allergic response to some allergens.
Zyflo® is NOT to be administered by EMTBs per Maryland Medical Protocols
Drug
Action:
Leukotriene
modifier (antiasthmatic)
Dose:
600 mg q.i.d.
Supplied
as:
600 mg tablets
Return
to So Many Medications...